T he Centers for Disease Control and Prevention (CDC) recently compared its annual surveillance Lyme numbers [those that meet the agency’s narrowly defined case definition] to the number of Lyme cases tallied in a database of major insurance claims from 2010 to 2018. The results of the study show that the CDC is still undercounting cases 1.
If you dig deep into the numbers, you see that the undercounting is much more severe in some areas—namely in southern and western states. This has huge implications for Lyme patients in those regions. Undercounting makes it much harder for them to get properly diagnosed and treated.
CDC undercounting of Lyme disease is more severe in some areas—namely in southern and western states.
It’s important that the CDC is acknowledging an extraordinary amount of undercounting, and it is also important that they are looking at other big data sources (insurance claims) to see how far off the mark they are. However, the degree to which the CDC surveillance system undercounts cases is not equally distributed geographically. States that are considered low-incidence states are disproportionately undercounted.
The table below shows the amount of underreporting reflected in the lower number of surveillance cases compared to the number of insurance claims in the CDC study in high-incidence, neighboring states, and low-incidence states:…..Join or login below to continue reading.